Peer Review History
| Original SubmissionFebruary 2, 2022 |
|---|
|
PONE-D-22-03299The case against 2D:4D: more data about its conflicting results on handedness, sexual orientation and sex differences.PLOS ONE Dear Dr. Turiegano, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Your manuscript has been assessed by two peer-reviewers and their reports are appended below. The reviewers comment that some aspects of the manuscript would benefit from additional explanation or clarification, and that the title of the study is confusing. In addition, the reviewers have requested some clarification regarding aspects of the statistical analysis described in this study. Could you please revise the manuscript to carefully address the concerns raised? Please submit your revised manuscript by Jan 02 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Maria Elisabeth Johanna Zalm, Ph.D Editorial Office PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in your Competing Interests section: “NO authors have competing interests” Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: “The experiments that allowed us to collect the analised data were supported by the Spanish Ministry for Science and Innovation [grant numbers: BFU2010-10981-E; ECO2015-66281-P; PID2019-105895GB-I00], the Ministry of Economics and Competitiveness [ECO2011-28750; ECO2012-33243] and by Department of Biology (UAM) Research Funds [BIOUAM05-2019].” We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: ‘ET- Spanish Ministry for Science and Innovation [grant numbers: BFU2010-10981-E; ECO2015-66281-P; PID2019-105895GB-I00]. (https://www.ciencia.gob.es/) ET- Ministry of Economics and Competitiveness [ECO2011-28750; ECO2012-33243] (https://portal.mineco.gob.es/) ET- Department of Biology (UAM) Research Funds [BIOUAM05-2019]. (https://www.uam.es/Ciencias/DBIO)” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors address a long-debated issue in the field – whether sex differences in 2D:4D is simply due to allometry or a result of prenatal androgen exposure. The authors thoroughly and fairly describe the state of the literature, and address many of the limitations of prior work by using a large sample to test the primary criticism against the use of 2D:4D (i.e., allometry). The authors find that sex differences in 2D:4D cannot be explained by allometry alone, and thus suggest that 2D:4D is a valid proxy for prenatal androgens, provided certain precautious are met. These considerations for future research are outlined (i.e., using large sample sizes and considering ethnicity beyond self-report – i.e., asking grandparents home country). As such, I recommend this manuscript be accepted for publication with minor revisions, as outlined below. --------------- Point-by-point comments: Title is confusing – it reads as though this will be an article with more conflicting data, and the data will be largely against the use of 2D:4D. Abstract: “The debate has also questioned..” this is the first mention of debate, so I would omit “also”. I would rephrase to something along the lines of: “However, this proxy has been met with criticism, especially in relation to other purported features associated with prenatal androgen such as handedness and sexual orientation.” Introduction: “considerable controversy over the past two years..” � its been much longer; for example, see: Kratochvíl, L., & Flegr, J. (2009). Differences in the 2nd to 4th digit length ratio in humans reflect shifts along the common allometric line. Biology letters, 5(5), 643-646. Line 142 “sexual differences” – do you mean sex differences or sexual orientation differences? Line 179 “posterior studies” – previous? Methods: Line 233 –“analised” analysed? Please provide more details on how measurements of digits were obtained (e.g., middle/centre of tip to palm?) Results/Discussion Could some of the variance due to allometry be accounted for by the role of androgens in body size? i.e., androgens contribute to sex differences in body size and 2D:4D, so some shared variance would be expected? It may be worth noting that prenatal androgens may only lead to same-sex sexual orientation among a subset of individuals (i.e., Swift-Gallant et al., 2019; PNAS finds that handedness only explains sexual orientation among <6% of non-heterosexual men; also see recent review by VanderLaan et al., 2022, Archives of Sex Beh), and so a relationship between these proxies for prenatal androgen and sexual orientation may not be found when looking at all gay men/non-heterosexual as one group. Reviewer #2: I have reviewed the manuscript and I think its well written and discussed. I do not have any issues with the title, abstract, introduction and discussion. I however, will like to recommend minor revisions in the methods and results section ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: MOSES BANYEH ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
In support of 2D:4D: more data exploring its conflicting results on handedness, sexual orientation and sex differences. PONE-D-22-03299R1 Dear Dr. Turiegano, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Also, please see Editor comments below for a few minor suggested edits. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ashlyn Swift-Gallant Guest Editor PLOS ONE Additional Editor Comments (optional): Below, I offer a few minor edits to consider in your proofs. Also, to preserve transparency in the review process, I must divulge that I was recently invited to serve as a guest editor and previously served as a reviewer. Please contact staff editor Dr. Maria Elisabeth Johanna Zalm if you have any concerns in regards to the handling of your manuscript. Suggested Edits: Abstract: line 21 – either remove“..the usually found..” or replace with “..the typically observed sex difference in this trait..” Introduction: It will be 2023 when this manuscript is in press; thus, references 15 and 16 will not be in the last two years (2019, 2020). As such, please revise “last two years” to either last four or five years. Line 104: change “…being the latter…” to “…the latter being..” Line 149: change “…women who suffer CAH…” to “…women with CAH…” Lines 216-218: remove “Indeed, some have been previously published, which minimizes self-selection sampling issues and observer bias problems.” – redundant. Table 1: indicate units of measurement (cm?) Line 514: “…non-heterosexual women show significant low 2D:4D values,…” please clarify whether you mean significantly lower than heterosexual women. |
| Formally Accepted |
|
PONE-D-22-03299R1 In support of 2D:4D: more data exploring its conflicting results on handedness, sexual orientation and sex differences. Dear Dr. Turiegano: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ashlyn Swift-Gallant Guest Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .